Minocycline topical gel - Foamix

Drug Profile

Minocycline topical gel - Foamix

Latest Information Update: 17 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Foamix
  • Class Amides; Anti-inflammatories; Antiacnes; Antibacterials; Dimethylamines; Neuroprotectants; Skin disorder therapies; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Age-related macular degeneration; Blepharitis; Chlamydial infections; Diabetic macular oedema; Glaucoma; Ophthalmic infections; Rosacea

Most Recent Events

  • 17 Jul 2018 No development reported - Clinical-Phase-Unknown for Age-related macular degeneration (Topical gel)
  • 17 Jul 2018 No development reported - Clinical-Phase-Unknown for Blepharitis (Topical gel)
  • 17 Jul 2018 No development reported - Clinical-Phase-Unknown for Chlamydial infections (Topical gel)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top